Distinct Cleavage Properties of Cathepsin B Compared to Cysteine Cathepsins Enable the Design and Validation of a Specific Substrate for Cathepsin B over a Broad pH Range.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
01 08 2023
Historique:
medline: 2 8 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: ppublish

Résumé

The biological and pathological functions of cathepsin B occur in acidic lysosomes and at the neutral pH of cytosol, nuclei, and extracellular locations. Importantly, cathepsin B displays different substrate cleavage properties at acidic pH compared to neutral pH conditions. It is, therefore, desirable to develop specific substrates for cathepsin B that measure its activity over broad pH ranges. Current substrates used to monitor cathepsin B activity consist of Z-Phe-Arg-AMC and Z-Arg-Arg-AMC, but they lack specificity since they are cleaved by other cysteine cathepsins. Furthermore, Z-Arg-Arg-AMC monitors cathepsin B activity at neutral pH and displays minimal activity at acidic pH. Therefore, the purpose of this study was to design and validate specific fluorogenic peptide substrates that can monitor cathepsin B activity over a broad pH range from acidic to neutral pH conditions. In-depth cleavage properties of cathepsin B were compared to those of the cysteine cathepsins K, L, S, V, and X via multiplex substrate profiling by mass spectrometry at pH 4.6 and pH 7.2. Analysis of the cleavage preferences predicted the tripeptide Z-Nle-Lys-Arg-AMC as a preferred substrate for cathepsin B. Significantly, Z-Nle-Lys-Arg-AMC displayed the advantageous properties of measuring high cathepsin B specific activity over acidic to neutral pHs and was specifically cleaved by cathepsin B over the other cysteine cathepsins. Z-Nle-Lys-Arg-AMC specifically monitored cathepsin B activity in neuronal and glial cells which were consistent with relative abundances of cathepsin B protein. These findings validate Z-Nle-Lys-Arg-AMC as a novel substrate that specifically monitors cathepsin B activity over a broad pH range.

Identifiants

pubmed: 37459182
doi: 10.1021/acs.biochem.3c00139
pmc: PMC10399199
doi:

Substances chimiques

Cathepsin B EC 3.4.22.1
Cathepsins EC 3.4.-
Cysteine K848JZ4886
Endopeptidases EC 3.4.-
Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2289-2300

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS109075
Pays : United States

Références

Biochim Biophys Acta. 2012 Jan;1824(1):68-88
pubmed: 22024571
Biochemistry. 2022 Feb 15;61(4):228-238
pubmed: 35119840
Proteomics Clin Appl. 2014 Jun;8(5-6):427-37
pubmed: 24677670
Neural Regen Res. 2020 Jan;15(1):25-29
pubmed: 31535638
J Cereb Blood Flow Metab. 2012 Oct;32(10):1919-32
pubmed: 22781336
Pharmacol Rev. 2022 Jul;74(3):600-629
pubmed: 35710131
Brain Res. 1994 Mar 21;640(1-2):68-80
pubmed: 8004466
FEBS Lett. 1991 Mar 25;280(2):307-10
pubmed: 2013328
Biochem J. 1988 Feb 15;250(1):1-8
pubmed: 2965576
Chem Sci. 2019 Jul 31;10(36):8461-8477
pubmed: 31803426
Arch Biochem Biophys. 2019 Jul 30;670:32-42
pubmed: 30807742
Exp Cell Res. 2018 Jan 1;362(1):180-187
pubmed: 29196167
Cancer Res. 1975 Sep;35(9):2594-9
pubmed: 167965
FEBS Lett. 1991 Mar 25;280(2):311-5
pubmed: 2013329
Cell Physiol Biochem. 2018;50(4):1585-1600
pubmed: 30359991
PLoS One. 2013 Apr 25;8(4):e62143
pubmed: 23634225
PLoS One. 2010 Jul 23;5(7):e11765
pubmed: 20668705
Blood. 2007 Apr 1;109(7):2903-11
pubmed: 17164343
Nat Cell Biol. 2019 Feb;21(2):133-142
pubmed: 30602725
ACS Chem Biol. 2021 Sep 17;16(9):1628-1643
pubmed: 34416110
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3327-31
pubmed: 28524
Neoplasia. 2008 May;10(5):481-8
pubmed: 18472965
Nat Methods. 2012 Nov;9(11):1095-100
pubmed: 23023596
Biochemistry. 1993 Jan 12;32(1):375-80
pubmed: 7678196
Biol Chem. 2009 Feb;390(2):175-9
pubmed: 19040356
Biochemistry. 1994 Dec 13;33(49):14800-6
pubmed: 7993907
Cell Death Discov. 2016 Feb 29;2:16012
pubmed: 27551506
J Cell Biol. 1987 Apr;104(4):1019-33
pubmed: 3558476
Genes Dev. 2000 Aug 15;14(16):2060-71
pubmed: 10950869
Gastroenterology. 2019 May;156(7):1979-1993
pubmed: 30776339
Am J Pathol. 2009 Dec;175(6):2540-56
pubmed: 19893049
Eur J Biochem. 1999 Feb;259(3):926-32
pubmed: 10092883
ASN Neuro. 2022 Jan-Dec;14:17590914221099112
pubmed: 35503242
Brain Res. 1990 Apr 16;513(2):181-92
pubmed: 2350688
ACS Chem Neurosci. 2021 Jul 7;12(13):2385-2398
pubmed: 34153188
Annu Rev Physiol. 1966;28:435-92
pubmed: 5322983
Breast Cancer Res. 2011;13(6):R115
pubmed: 22093547
Biol Chem. 2016 Dec 21;398(3):289-301
pubmed: 28002019
Biochem Biophys Res Commun. 2013 Aug 16;438(1):20-5
pubmed: 23867824
Mol Cell Proteomics. 2020 Jun;19(6):1017-1034
pubmed: 32295833
J Gen Physiol. 2013 Jun;141(6):705-20
pubmed: 23712550
Front Immunol. 2018 Jun 21;9:1427
pubmed: 29977244
Annu Rev Physiol. 2015;77:57-80
pubmed: 25668017
Neurobiol Dis. 2001 Feb;8(1):19-31
pubmed: 11162237
J Proteome Res. 2014 Jun 6;13(6):3114-20
pubmed: 24766612
J Neurochem. 2008 Jul;106(1):56-69
pubmed: 18363826
Neurochem Int. 2019 Jun;126:178-186
pubmed: 30904670
J Neurosci Res. 2011 Jul;89(7):1031-42
pubmed: 21488093
Neurobiol Dis. 2010 Oct;40(1):293-302
pubmed: 20600913
Cell Chem Biol. 2016 Jul 21;23(7):793-804
pubmed: 27427229
Life Sci. 2018 Mar 1;196:102-109
pubmed: 29366749
Biol Chem. 2010 Aug;391(8):923-35
pubmed: 20536394
Cancer Res. 1978 Nov;38(11 Pt 1):3751-7
pubmed: 29704
Nat Commun. 2020 Jan 13;11(1):229
pubmed: 31932607
J Neurotrauma. 2013 Apr 1;30(7):597-607
pubmed: 23186154
Annu Rev Physiol. 2012;74:69-86
pubmed: 22335796
J Biol Chem. 2008 Jul 4;283(27):19140-50
pubmed: 18469004
ACS Omega. 2021 May 13;6(20):13033-13056
pubmed: 34056454

Auteurs

Michael C Yoon (MC)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States.
Biomedical Sciences Graduate Program, University of California, La Jolla, San Diego, California 92093, United States.

Von Phan (V)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States.
Biomedical Sciences Graduate Program, University of California, La Jolla, San Diego, California 92093, United States.

Sonia Podvin (S)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States.

Charles Mosier (C)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States.

Anthony J O'Donoghue (AJ)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States.

Vivian Hook (V)

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, California 92093, United States.
Biomedical Sciences Graduate Program, University of California, La Jolla, San Diego, California 92093, United States.
Department of Neurosciences and Department of Pharmacology, School of Medicine, University of California, La Jolla, San Diego, California 92093, United States.

Articles similaires

Animals Huntington Disease Mitochondria Neurons Mice
Humans Stomach Neoplasms Macrophages Tumor Microenvironment Disease Progression

Mutational analysis of Phanerochaete chrysosporium´s purine transporter.

Mariana Barraco-Vega, Manuel Sanguinetti, Gabriela da Rosa et al.
1.00
Phanerochaete Fungal Proteins Purines Aspergillus nidulans DNA Mutational Analysis
Humans Bipolar Disorder Mendelian Randomization Analysis Cathepsin H Cathepsin B

Classifications MeSH